ALR Technologies SGALRTF +15.38% EBIT per Share is $-0.00 as of Dec. 2025. The stock has 3 warning signs investors should review. Among 691 Medical Devices & Instruments companies, ALR Technologies SG ranks better than 57.02% on this metric.
ALR Technologies SG's EBIT per Share for the
six
months ended in Dec. 2025 was $-0.00.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.00.
During the past 3 years, the average EBIT per Share Growth Rate was 14.50% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 9.30% per year.
During the past 10 years, the average EBIT per Share Growth Rate was -1.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for ALR Technologies SG's EBIT per Share or its related term are showing as below:
ALRTF'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -55.4 Med: 13.65 Max: 38.2
Current: 14.5
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of ALR Technologies SG was 38.20% per year. The lowest was -55.40% per year. And the median was 13.65% per year.
ALRTF's 3-Year EBIT Growth Rate is ranked better than 57.02% of 691
companies
in the Medical Devices & Instruments industry
Industry Median: 9.6
vs ALRTF: 14.50
ALR Technologies SG (OTCPK:ALRTF) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
ALR Technologies SG EBIT per Share Related Terms
ALR Technologies SG EBIT per Share Historical Data
* Premium members only.
The historical data trend for ALR Technologies SG's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ALR Technologies SG (ALRTF) has a EBIT per Share of $-0.00 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on ALR Technologies SG and its competitors. According to the industry distribution chart, ALR Technologies SG ranks #297 out of 691 companies in the Medical Devices & Instruments industry, placing it in the top 43%.
Is ALR Technologies SG's EBIT per Share too high?
ALR Technologies SG's current EBIT per Share is $-0.00. Based on the distribution chart, ALR Technologies SG ranks #297 out of 691 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does ALR Technologies SG's EBIT per Share compare to CODX and SINT?
According to the Medical Devices & Instruments industry distribution chart, ALR Technologies SG ranks #297 out of 691 companies for EBIT per Share. This puts ALR Technologies SG in the upper half of its industry. The industry median EBIT per Share is 9.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.60, based on 691 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on ALR Technologies SG and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ALR Technologies SG's current EBIT per Share is $-0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ALR Technologies SG stock overvalued right now?
ALR Technologies SG (ALRTF) has a current EBIT per Share of $-0.00. The current EBIT per Share is $-0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For ALR Technologies SG (ALRTF), the current EBIT per Share is $-0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ALR Technologies SG Ltd is a medical device company that focuses on commercializing its Health-e-Connect System. The company is a data management company that developed a comprehensive approach to diabetes care that includes an FDA-cleared and HIPAA-compliant Diabetes Solution product that can collect data from BGM and CGM; a patent-pending Predictive A1C algorithm to track treatment success between lab reports; and an FDA-cleared Insulin Dosing Adjustment program. Geographically, it operates in the United States and Singapore.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALRTF has been successfully added to your 